|
Pipeline Setbacks for Big Pharma: AZ, Sanofi, Novartis, GSK Take Hits
Big Pharma saw several pipeline setbacks in December, with AstraZeneca, Sanofi, Novartis and GlaxoSmithKline (GSK) announcing trial failures, a study termination and the end of a drug development program.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives